Top AstraZeneca I/O exec jumps to Seattle Genetics as first CCO; Woodford fund downgraded as woes mount
→ Seattle Genetics has raided the top ranks at AstraZeneca for its first chief commercial officer. Robin Taylor is making the leap from the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
